why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
300×250 Ad Slot

Drug FDA Status

Showing 10 of 139 result(s) (Page 1 of 14)
Drug Name: Lynkuet

Active Ingredient: elinzanetant

Approval Date: 2025-10-24

Description: To treat moderate-to-severe vasomotor symptoms due to menopause

Drug Name: Jascayd

Active Ingredient: nerandomilast

Approval Date: 2025-10-07

Description: To treat idiopathic pulmonary fibrosis

Drug Name: Rhapsido

Active Ingredient: remibrutinib

Approval Date: 2025-09-30

Description: To treat chronic spontaneous urticaria in adults who remain symptomatic despite H1 antihistamine treatment

Drug Name: Inluriyo

Active Ingredient: imlunestrant

Approval Date: 2025-09-25

Description: To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, estrogen receptor-1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy

Drug Name: Palsonify

Active Ingredient: paltusotine

Approval Date: 2025-09-25

Description: To treat acromegaly in adults who had an inadequate response to surgery and/or for whom surgery is not an option

Drug Name: Keytruda Qlex

Active Ingredient: pembrolizumab and berahyaluronidase alfa-pmph

Approval Date: 2025-09-19

Description: To treat adult and pediatric (12 years and older) solid tumor indications approved for the intravenous formulation of pembrolizumab 

Drug Name: Forzinity

Active Ingredient: elamipretide

Approval Date: 2025-09-19

Description: To improve muscle strength in patients with Barth syndrome weighing at least 30 kg

Drug Name: Wayrilz

Active Ingredient: rilzabrutinib

Approval Date: 2025-08-29

Description: To treat persistent or chronic immune thrombocytopenia that has not sufficiently responded to immunoglobulins, anti-D therapy, or corticosteroids

Drug Name: Dawnzera

Active Ingredient: donidalorsen

Approval Date: 2025-08-21

Description: To prevent attacks of hereditary angioedema

Drug Name: Brinsupri

Active Ingredient: brensocatib

Approval Date: 2025-08-12

Description: To treat non-cystic fibrosis bronchiectasis

300×250 Ad Slot